Nanotechnology in cancer drug delivery and selective targeting
KB Sutradhar, ML Amin - International scholarly research …, 2014 - Wiley Online Library
Nanoparticles are rapidly being developed and trialed to overcome several limitations of
traditional drug delivery systems and are coming up as a distinct therapeutics for cancer …
traditional drug delivery systems and are coming up as a distinct therapeutics for cancer …
The inflammatory chemokines CCL2 and CCL5 in breast cancer
G Soria, A Ben-Baruch - Cancer letters, 2008 - Elsevier
A causal role was recently attributed to inflammation in many malignant diseases, including
breast cancer. The different inflammatory mediators that are involved in this disease include …
breast cancer. The different inflammatory mediators that are involved in this disease include …
Ligand-modified cell membrane enables the targeted delivery of drug nanocrystals to glioma
The safe and efficient delivery of chemotherapeutic agents remains critical to anticancer
therapy. Herein, we report on a targeted drug delivery system based upon a modified cell …
therapy. Herein, we report on a targeted drug delivery system based upon a modified cell …
Tumor-reprogrammed resident T cells resist radiation to control tumors
A Arina, M Beckett, C Fernandez, W Zheng… - Nature …, 2019 - nature.com
Successful combinations of radiotherapy and immunotherapy depend on the presence of
live T cells within the tumor; however, radiotherapy is believed to damage T cells. Here …
live T cells within the tumor; however, radiotherapy is believed to damage T cells. Here …
Flow shear stress regulates endothelial barrier function and expression of angiogenic factors in a 3D microfluidic tumor vascular model
Endothelial cells lining blood vessels are exposed to various hemodynamic forces
associated with blood flow. These include fluid shear, the tangential force derived from the …
associated with blood flow. These include fluid shear, the tangential force derived from the …
[HTML][HTML] miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells
A key step in angiogenesis is the upregulation of growth factor receptors on endothelial
cells. Here, we demonstrate that a small regulatory microRNA, miR-296, has a major role in …
cells. Here, we demonstrate that a small regulatory microRNA, miR-296, has a major role in …
Dual-modified novel biomimetic nanocarriers improve targeting and therapeutic efficacy in glioma
S Fu, M Liang, Y Wang, L Cui, C Gao… - … applied materials & …, 2018 - ACS Publications
Glioma is a fatal disease with limited treatment options and very short survival. Although
chemotherapy is one of the most important strategies in glioma treatment, it remains …
chemotherapy is one of the most important strategies in glioma treatment, it remains …
STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells
NN Khodarev, M Beckett, E Labay… - Proceedings of the …, 2004 - National Acad Sciences
Nu61, a radiation-resistant human tumor xenograft, was selected from a parental
radiosensitive tumor SCC-61 by eight serial cycles of passage in athymic nude mice and in …
radiosensitive tumor SCC-61 by eight serial cycles of passage in athymic nude mice and in …
Glycosaminoglycan-based hydrogels to modulate heterocellular communication in in vitro angiogenesis models
Angiogenesis, the outgrowth of blood vessels, is crucial in development, disease and
regeneration. Studying angiogenesis in vitro remains challenging because the capillary …
regeneration. Studying angiogenesis in vitro remains challenging because the capillary …
[HTML][HTML] Serum inflammatory markers in diabetic retinopathy
AD Meleth, E Agrón, CC Chan, GF Reed… - … & visual science, 2005 - arvojournals.org
purpose. To evaluate the association of serum factors with the severity of diabetic
retinopathy and to assess their presence in retinal tissue obtained at autopsy. methods. The …
retinopathy and to assess their presence in retinal tissue obtained at autopsy. methods. The …